Immuron Ltd — Capital/Financing Update 2013

May 2, 2013

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New Issue Announcement, Application for Quotation of Additional Securities and Agreement.

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12

Name of Entity:

Immuron Limited (ASX: IMC)

ACN:

80 063 114 045

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

• 1 +Class of +securities issued or to be issued Fully Paid Ordinary Shares (IMC)

• 2 Number of[+] securities issued or to be a) 94,638,844 issued (if known) or maximum number b) 507,247,519

• which may be issued

• 3 Principal terms of the[+] securities (eg, if Fully Paid Ordinary Shares (IMC)

• options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

• See chapter 19 for defined terms. Appendix 3B Page 1

01/08/2012

4 Do the[+] securities rank equally in all Yes, (IMC) respects from the date of allotment with an existing[+] class of quoted[+] securities? If the additional securities do not rank equally, please state:

• the date from which they do

• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

• 5 Issue price or consideration

a) $283,916.30 b) $1,521,742.56

• 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets)

a) Issue of new securities to eligible subscribers of the Renounceable Rights Issue as detailed in the prospectus announced to the ASX on 27 March 2013. b) Issue of securities to the Sub-Underwriters of the Renounceable Rights Issue in accordance with the Underwriting Agreement and Prospectus dated 27 March 2013.

6a Is the entity an[+] eligible entity that has Yes obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution 26 November 2012 under rule 7.1A was passed 6c Number of +securities issued without Nil security holder approval under rule 7.1 6d Number of[+] securities issued with security Nil holder approval under rule 7.1A 6e Number of[+] securities issued with security Nil holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

• See chapter 19 for defined terms. Appendix 3B Page 2

01/08/2012

6f Number of securities issued under an a) 94,638,844 exception in rule 7.2 b) 507,247,519

• 6g If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

N/A

• 6h If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

N/A

• 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements

Refer to the attached Appendix 1

• 7 Dates of entering +securities into Monday 6[th] May 2013 uncertificated holdings or despatch of certificates

• 8 Number and[+] class of all[+] securities quoted on ASX (including the securities in section 2 if applicable)

Number	+Class
1,016,066,420 2,752,230 116,024,381	Fully Paid Ordinary Shares (IMC) Listed Options exercisable at $0.12 on or before 15 Dec 2013 (IMCO) Listed Options exercisable at $0.04 on or before 30 April 2015 (IMCOA)

• See chapter 19 for defined terms. Appendix 3B Page 3

01/08/2012

• 9 Number and[+] class of all[+] securities not quoted on ASX (including the securities in section 2 if applicable)

• 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

	Number		+Class(Options over OrdinaryShares)
	Amount		Exercise Expiration			ASX Code
			Price Date
	750,000 $0.0945 31 May 2013					IMCJB2
	4,000,000 $0.0700 30 June 2014					IMCSO
	3,000,000 $0.0400 30 June 2015					IMCSO1
	7,000,000 $0.0400 1 Nov 2017					IMCSO2
	579,736 $0.0497 30 Nov 2021					IMCRM1
	1,186,729 $0.0480 17 Jan 2022					IMCRM2
	*155,317,501 $0.0100 31 Mar 2016					“TBA”
	171,833,966 Total
*These options are to be issued, subject to shareholder approval
	being granted at the General Meeting of the Company to be
	held on 17thMay 2013, to the Underwriter and its
	sub-underwriters of the Renounceable Rights Issue						in
	accordance	with the Underwriting Agreement			and Prospectus
	announced to the ASX on 27 March 2013.
	Number		+Class(Convertible Note)
	Maximum No.		Details			Expiration
	of Ordinary					Date
	Shares
	20,525,873		This is the maximum number of			23 Dec 2014
			fully paid ordinary shares that
			can be issued to Paladin Labs Inc.
			under the terms of the
			convertible debenture entered
			into in December 2011.
			The conversion into fully paid
			ordinary shares is to be no later
			than 23 Dec 2014
	10,253,700		Maximum number of fully paid
			ordinary shares that can be
			issued to Paladin labs Inc. under
			the terms of the Tranche	2
			Convertible Debenture. The
			conversion into fully paid
			ordinary shares is to be no later
			than January 2015.
	30,779,573		Total

Number	+Class(Convertible Note)	+Class(Convertible Note)
Maximum No. of Ordinary Shares	Details	Expiration Date
20,525,873 10,253,700	This is the maximum number of fully paid ordinary shares that can be issued to Paladin Labs Inc. under the terms of the convertible debenture entered into in December 2011. The conversion into fully paid ordinary shares is to be no later than 23 Dec 2014 Maximum number of fully paid ordinary shares that can be issued to Paladin labs Inc. under the terms of the Tranche 2 Convertible Debenture. The conversion into fully paid ordinary shares is to be no later than January 2015.	23 Dec 2014
30,779,573	Total
Unchanged

• See chapter 19 for defined terms. Appendix 3B Page 4

01/08/2012

Part 2 - Bonus issue or pro rata issue

11	Is security holder approval required?
12	Is the issue renounceable or	non-
	renounceable?
13	Ratio in which the+securities will be offered
14	+Class of+securities to which the offer relates
15	+Record date to determine entitlements
16	Will holdings on different registers	(or
	subregisters) be aggregated for calculating
	entitlements?
17	Policy for deciding entitlements in relation		to
	fractions
18	Names of countries in which the entity has
	+security holders who will not be sent	new
	issue documents
	Note: Security holders must be told how	their
	entitlements are to be dealt with.
	Cross reference: rule 7.7.
19	Closing date for receipt of acceptances		or
	renunciations
20	Names of any underwriters
21	Amount of any underwriting fee		or
	commission
22	Names of any brokers to the issue
23	Fee or commission payable to the broker		to
	the issue
24	Amount of any handling fee payable		to
	brokers who lodge acceptances		or
	renunciations on behalf of+security holders
25	If the issue is contingent on+security holders’
	approval, the date of the meeting

• See chapter 19 for defined terms. Appendix 3B Page 5

01/08/2012

• 26 Date entitlement and acceptance form and prospectus or Product Disclosure Statement will be sent to persons entitled

• 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders

• 28 Date rights trading will begin (if applicable)

• 29 Date rights trading will end (if applicable)

• 30 How do +security holders sell their entitlements in full through a broker?

• 31 How do[+] security holders sell part of their entitlements through a broker and accept for the balance?

• 32 How do[+] security holders dispose of their entitlements (except by sale through a broker)?

• 33 +Despatch date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

34	Type of securities	Type of securities
	(tick one)
(a)		Securities described in Part 1
(b)		All other securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share
		securities when restriction ends, securities issued on expiry or conversion of convertible securities

• See chapter 19 for defined terms. Appendix 3B Page 6

01/08/2012

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

• 35[If the ] +securities, and the number and percentage of additional[+][securities are ][+][equity securities, the names of the 20 largest holders of the additional ] +securities held by those holders

• 36[If the ][+][securities are ][+][equity securities, a distribution schedule of the additional ][+][securities setting ] out the number of holders in the categories

• 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over

• 37[A copy of any trust deed for the additional ][+][securities ]

Entities that have ticked box 34(b)

• 38 Number of securities for which[+] quotation is sought

• 39 Class of[+] securities for which quotation is sought

• 40 Do the[+] securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

If the additional securities do not rank equally, please

state:

• the date from which they do

• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

• 41 Reason for request for quotation now

• (if issued upon conversion of another security, clearly identify that other security)

Example: In the case of restricted securities, end of restriction

period

• 42 Number and[+] class of all[+] securities quoted on ASX (including the securities in clause 38)

Number +Class

• See chapter 19 for defined terms. Appendix 3B Page 7

01/08/2012

Quotation Agreement

• 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the +securities on any conditions it decides.

• 2 We warrant the following to ASX.

• The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

• There is no reason why those[+] securities should not be granted[+] quotation.

• An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

• Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.

• If we are a trust, we warrant that no person has the right to return the[+] securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

• 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

• 4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

==> picture [99 x 39] intentionally omitted <==

Sign Here: Company Secretary Date: Friday 3[rd] May 2013 Print Name: Peter Vaughan

==> picture [38 x 23] intentionally omitted <==

The CFO Solution

3 May 2013

• See chapter 19 for defined terms. Appendix 3B Page 8

01/08/2012

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for[+] eligible entities

Introduced 01/08/12

Part 1

*All calculations are based on a post consolidation basis.

Rule 7.1 – Issues exceeding 15% of capital

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated Insert number of fully paid ordinary securities on 372,443,967 issue 12 months before date of issue or agreement to issue Add the following: • Number of fully paid ordinary securities issued 601,886,363 (LR 7.2) in that 12 month period under an exception in rule 7.2 41,377,590 (LR 7.3) • Number of fully paid ordinary securities issued in that 12 month period with shareholder approval

• Number of partly paid ordinary securities that became fully paid in that 12 month period

• Note: • Include only ordinary securities here – other classes of equity securities cannot be added

• • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

• • It may be useful to set out issues of securities on different dates as separate line items

• Subtract the number of fully paid ordinary Nil securities cancelled during that 12 month period “A” 1,015,707,920

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A”	Step 2: Calculate 15% of “A”
“B”	0.15 [Note: this value cannot be changed]
Multiply“A” by 0.15	152,356,188

• See chapter 19 for defined terms.

Appendix 3B Page 9

01/08/2012

Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period not counting those issued:

• Under an exception in rule 7.2

• Under rule 7.1A

• With security holder approval under rule 7.1 or 938,236 rule 7.4

• Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities

• • Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed

• • It may be useful to set out issues of securities on different dates as separate line items

• “C” 938,236

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1	Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1	Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1
	“A” x 0.15 Note: number must be same as shown in Step 2	152,356,188
	Subtract“C” Note: number must be same as shown in Step 3	938,236
	Total[“A” x 0.15] – “C”	151,417,952 [Note: this is the remaining placement capacity under rule 7.1]

• See chapter 19 for defined terms. Appendix 3B Page 10

01/08/2012

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 1,015,707,920 Note: Number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

Step 2: Calculate 10% of “A”	Step 2: Calculate 10% of “A”	Step 2: Calculate 10% of “A”
“D”		0.10 Note: This value cannot be changed
Multiply“A” by 0.10		101,570,792

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

Notes:

• This applies to equity securities – not just ordinary securities

• Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

• Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

• It may be useful to set out issues of securities on different dates as separate line items

“E” Nil

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

“A” x 0.10 Note: number must be same as shown in Step 2 1,015,707,920 Subtract “E” Note: number must be same as shown in Step 3 Nil Total [“A” x 0.10] – “E” 101,570,792 Note: This is the remaining placement capacity under rule 7.1A

==> picture [148 x 35] intentionally omitted <==

IMMURON LIMITED

ORDINARY FULLY PAID SHARES As of 03 May 2013

Top Holders Snapshot - Ungrouped

Composition : ORD

Rank	Name	Address	Units	% of Units
1.	GRANDLODGE PTY LTD		101,626,929	10.00
2.	CHIMAERA CAPITAL LTD		70,000,000	6.89
	MR PETER ANASTASIOU + MRS KRISTINE
3.	PATRICIA ANASTASIOU <ANASTASIOU SUPER		66,700,000	6.56
	FUND A/C>
4.	HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD		59,164,094	5.82
5.	MR STEPHEN ANASTASIOU		50,000,000	4.92
6.	MR DAVID ANTHONY PLUSH + MRS ANN LOUISE PLUSH		33,363,000	3.28
7.	CAPITAL CONCERNS PTY LTD S/F A/C>		30,000,000	2.95
8.	DR RUSSELL KAY HANCOCK		25,000,000	2.46
9.	CAPITAL CONCERNS PTY LIMITED FAMILY SUPER FUND A/C>		24,627,723	2.42
10.	INSYNC INVESTMENTS PTY LTD SUPER FUND NO 1 A/C>		21,830,234	2.15
11.	G & N LORD SUPERANNUATION PTY LTD SUPERANNUATION FUND A/C>		20,380,234	2.01
12.	SOMNUS PTY LTD A/C>		20,000,000	1.97
13.	KIRZY PTY LTD		14,445,932	1.42
14.	NUTSVILLE PTY LTD A/C>		12,922,482	1.27

Page 1 of 2

Rank	Name	Address	Units	% of Units
15.	ADVANCE PUBLICITY PTY LTD FAMILY A/C>		11,170,000	1.10
16.	MR HAMISH SALMON		10,567,450	1.04
	MRS JACLYN STOJANOVSKI + MR CHRIS RETZOS
17.	+ MRS SUSIE RETZOS <RETZOS EXECUTIVE S/F		10,400,645	1.02
	A/C>
18.	WESTPARK OPERATIONS PTY LTD OPERATIONS UNIT>		10,253,489	1.01
19.	ALAVEN CONSUMER HEALTHCARE INC		9,017,229	0.89
20.	BALARELLI PTY LTD		8,461,241	0.83
Totals:	Top 20 holders of ORDINARY FULLY PAID SHARES		609,930,682	60.03
Total Remaining Holders Balance			406,135,738	39.97

Page 2 of 2

==> picture [135 x 35] intentionally omitted <==

IMMURON LIMITED

ORDINARY FULLY PAID SHARES As of 03 May 2013

Range of Units Snapshot

Range of Units Snapshot				Composition : ORD
	Range	Total holders	Units	% of Issued Capital
	1 - 1,000	91	48,120	0.00
	1,001 - 5,000	319	987,224	0.10
	5,001 - 10,000	253	2,162,336	0.21
10,001 - 100,000		629	27,305,154	2.69
100,001 -	9,999,999,999	578	985,563,586	97.00
	Rounding			0.00
	Total	1,870	1,016,066,420	100.00
Unmarketable Parcels
	Minimum Parcel Size		Holders	Units
Minimum $ 500.00 parcel at $ 0.0000 per unit		0	0	0

Page 1 of 1